Mitsubishi UFJ Trust & Banking’s Adaptive Biotechnologies ADPT Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$135K	Buy	+6,296	New	+$96.5K	﹤0.01%	1448

Other funds holding ADPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's ADPT Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 6,296 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #1448 among its holdings.

123 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 6,296 shares of Adaptive Biotechnologies worth $135K as of Q2 2026.
Adaptive Biotechnologies was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Adaptive Biotechnologies made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1448 holding.
123 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.